Giovanni Graziano

11PUBLICATIONS
59CO-AUTHORS
Biologically active moleculesCell physiologyRegenerative medicine (incl. stem cells)Molecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 31, 2026
Discovery of a Peripherally Directed CB1 Receptor Antagonist That Restores Insulin Signaling in Adipocytes.

|Oct 27, 2026
N-Adamantyl-1-Pentyl-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide and N-(Adamantan-1-Yl)-2-(Alkyloxy)benzamide Derivatives as Fluorescent Probes for Selective CB2R Targeting.

|Oct 23, 2026
Design and Development of New Dual Target Agents, Cannabinoid Subtype 2 Receptor (CB2R) Agonists, and Fatty Acid Amide Hydrolase (FAAH) Inhibitors against Neurodegeneration.

|Oct 23, 2026
From Structurally Diverse Sigma-1 (σ1) Receptor Reference Ligands to Live-Cell Probes: Fluorescent Phenoxyalkylpiperidines for the Detection of σ1 Receptor.

|Aug 14, 2026
From 18F‑MC225 to Conformationally Free Derivatives.

|Jul 08, 2026
Dysregulation of Human ClpP Using Small Molecules with Piperazine-Based Scaffold for Diffuse Intrinsic Pontine Glioma Therapy Validated by Patient-Derived Tumor Organoids.

Pageof 2

Frequent Collaborators

9 joint publications

Marialessandra Contino

9 joint publications

Maria Grazia Perrone

5 joint publications

Angela Stefanachi

5 joint publications

Eddy Sotelo